成人起病青光眼的遗传基础:近期进展与未来方向
本文综述原发性开角型青光眼、原发性闭角型青光眼和剥脱性青光眼的遗传学进展。全基因组关联研究已发现百余个与青光眼风险相关的遗传标记,但难以识别实际效应基因;全外显子组测序正在揭示新的改变蛋白质的编码序列变异,有助于理解发病机制并预测风险。
要点
- 全基因组关联研究已发现超过一百个与青光眼风险相关的遗传标记,但难以识别实际效应基因。
- 全外显子组测序正在大型人群研究和家系研究中揭示新的改变蛋白质的编码序列遗传变异。
- 综述涵盖原发性开角型、原发性闭角型和剥脱性青光眼,这三类占全球青光眼病例的绝大多数。
核心结论
- 全外显子组测序正在揭示新的改变蛋白质的遗传变异,可丰富对青光眼发病机制的理解,并可能用于预测青光眼风险和指导新治疗策略。
研究设计与样本
- 本文为综述,覆盖原发性开角型青光眼、原发性闭角型青光眼和剥脱性青光眼的遗传学近期进展。
- 综述讨论研究方法学进展如何发现新风险基因,以及后续生物学研究如何界定遗传序列变异所编码的风险在患者中的作用。
主要发现
- 观察性研究已确立青光眼发病和进展存在很强的可遗传成分。
- 以单核苷酸多态性(SNP)为中心的一系列全基因组关联研究(GWAS)已产生超过一百个与青光眼风险相关的遗传标记。
- GWAS的不足在于难以识别导致疾病发病机制的实际效应基因。
- 研究组已开始进行全外显子组测序,以评估改变蛋白质的编码序列遗传变异对青光眼风险的贡献。
- 在大型人群研究和家系研究中采用全外显子组测序,正在揭示新的改变蛋白质的遗传变异。
局限性
- GWAS研究的不足在于难以识别导致疾病发病机制的实际效应基因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glaucoma, a diverse group of eye disorders that results in the degeneration of retinal ganglion cells, is the world's leading cause of irreversible blindness. Apart from age and ancestry, the major risk factor for glaucoma is increased intraocular pressure (IOP). In primary open-angle glaucoma (POAG), the anterior chamber angle is open but there is resistance to aqueous outflow. In primary angle-closure glaucoma (PACG), crowding of the anterior chamber angle due to anatomical alterations impede aqueous drainage through the angle. In exfoliation syndrome and exfoliation glaucoma, deposition of white flaky material throughout the anterior chamber directly interfere with aqueous outflow. Observational studies have established that there is a strong hereditable component for glaucoma onset and progression. Indeed, a succession of genome wide association studies (GWAS) that were centered upon single nucleotide polymorphisms (SNP) have yielded more than a hundred genetic markers associated with glaucoma risk. However, a shortcoming of GWAS studies is the difficulty in identifying the actual effector genes responsible for disease pathogenesis. Building on the foundation laid by GWAS studies, research groups have recently begun to perform whole exome-sequencing to evaluate the contribution of protein-changing, coding sequence genetic variants to glaucoma risk. The adoption of this technology in both large population-based studies as well as family studies are revealing the presence of novel, protein-changing genetic variants that could enrich our understanding of the pathogenesis of glaucoma. This review will cover recent advances in the genetics of primary open-angle glaucoma, primary angle-closure glaucoma and exfoliation glaucoma, which collectively make up the vast majority of all glaucoma cases in the world today. We will discuss how recent advances in research methodology have uncovered new risk genes, and how follow up biological investigations could be undertaken in order to define how the risk encoded by a genetic sequence variant comes into play in patients. We will also hypothesise how data arising from characterising these genetic variants could be utilized to predict glaucoma risk and the manner in which new therapeutic strategies might be informed.
引用
- Wang Z, Wiggs JL, Aung T, et al. The genetic basis for adult onset glaucoma: Recent advances and future directions. Prog Retin Eye Res. 2022. PMID: 35589495. doi:10.1016/j.preteyeres.2022.101066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。